RxDoctor Payments Data

Megan Devlin, NP

Adult Health · Hackensack, NJNPI 1659654952

Payments from drug & device makers

$2,590in general payments, 2019–2025

Across 48 payments — averaging $53.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$953
  • Medtronic$913
  • Coloplast$184
  • Boston Scientific$179
  • Tolmar, Inc.$51
  • Urogen Pharma, Inc.$45
  • plus $265 from 11 others

What the payments were for

  • Speaking & faculty fees$311%
  • Travel & lodging$1,24748%
  • Food & beverage$1,28550%
  • Education$271%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,590 in reported general payments places this provider in the 85th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$81,511
Medicare patients
507
Services billed
2,310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron161$97,331
MyrbetriqMirabegron153$84,924
Estradiol250$14,555
Methenamine Hippurate151$8,173
PremarinEstrogens, Conjugated15$6,445
Fesoterodine Fumarate ErFesoterodine Fumarate11$1,671
NitrofurantoinNitrofurantoin Macrocrystal28$1,231
Cefdinir70$1,098
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst121$954
Oxybutynin Chloride ErOxybutynin Chloride42$808
Solifenacin Succinate22$715
Cephalexin104$658
Ciprofloxacin Hcl55$255
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$198
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim53$193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$31$97,331161 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →